- Home
- PRLD vs OKUR Comparison
PRLD vs OKUR Comparison
Compare PRLD & OKUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRLD
- OKUR
- Stock Information
- Founded
- PRLD 2016
- OKUR 2011
- Country
- PRLD United States
- OKUR United States
- Employees
- PRLD N/A
- OKUR N/A
- Industry
- PRLD Medicinal Chemicals and Botanical Products
- OKUR
- Sector
- PRLD Health Care
- OKUR
- Exchange
- PRLD Nasdaq
- OKUR NYSE
- Market Cap
- PRLD 73.7M
- OKUR 77.2M
- IPO Year
- PRLD 2020
- OKUR N/A
- Fundamental
- Price
- PRLD $1.05
- OKUR $5.79
- Analyst Decision
- PRLD Strong Buy
- OKUR Strong Buy
- Analyst Count
- PRLD 2
- OKUR 3
- Target Price
- PRLD $4.50
- OKUR $36.00
- AVG Volume (30 Days)
- PRLD 611.2K
- OKUR 176.8K
- Earning Date
- PRLD 02-13-2025
- OKUR 02-14-2025
- Dividend Yield
- PRLD N/A
- OKUR N/A
- EPS Growth
- PRLD N/A
- OKUR N/A
- EPS
- PRLD N/A
- OKUR N/A
- Revenue
- PRLD $3,000,000.00
- OKUR N/A
- Revenue This Year
- PRLD N/A
- OKUR N/A
- Revenue Next Year
- PRLD N/A
- OKUR N/A
- P/E Ratio
- PRLD N/A
- OKUR N/A
- Revenue Growth
- PRLD N/A
- OKUR N/A
- 52 Week Low
- PRLD $0.80
- OKUR $5.75
- 52 Week High
- PRLD $6.80
- OKUR $20.00
- Technical
- Relative Strength Index (RSI)
- PRLD 45.27
- OKUR N/A
- Support Level
- PRLD $0.98
- OKUR N/A
- Resistance Level
- PRLD $1.43
- OKUR N/A
- Average True Range (ATR)
- PRLD 0.12
- OKUR 0.00
- MACD
- PRLD -0.02
- OKUR 0.00
- Stochastic Oscillator
- PRLD 14.14
- OKUR 0.00
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About OKUR ONKURE THERAPEUTICS INC
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.